Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis

ConclusionsAttenuated cardiomyocyte growth response after stimulation with patient plasma in vitro is an independent risk factor for adverse cardiac events in ATTR patients

http://link.springer.com/10.1007/s00392-020-01801-y

Source: Clinical Research in Cardiology - January 22, 2021 Category: Cardiology Source Type: research